🐜
|
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
40 auth.
F. Minoia,
S. Davì,
A. Horne,
E. Demirkaya,
F. Bovis,
Caifeng Li,
K. Lehmberg,
S. Weitzman,
A. Insalaco,
C. Wouters,
S. Shenoi,
G. Espada,
S. Ozen,
J. Antón,
R. Khubchandani,
...
R. Russo,
P. Pal,
O. Kasapcopur,
P. Miettunen,
D. Maritsi,
R. Merino,
B. Shakoory,
M. Alessio,
V. Chasnyk,
H. Sanner,
Yihong Gao,
Z. Huasong,
T. Kitoh,
T. Avčin,
M. Fischbach,
M. Frosch,
A. Grom,
A. Huber,
M. Jelušić,
S. Sawhney,
Y. Uziel,
N. Ruperto,
A. Martini,
R. Cron,
A. Ravelli
|
8 |
2014 |
8 🐜
|
🐜
|
Functional rare and low frequency variants in BLK and BANK1 contribute to human lupus
41 auth.
S. Jiang,
V. Athanasopoulos,
J. Ellyard,
Aaron Chuah,
J. Cappello,
Amelia Cook,
Savit B. Prabhu,
Jacob Cardenas,
Jinghua Gu,
M. Stanley,
Jonathan A. Roco,
I. Papa,
M. Yabas,
G. Walters,
G. Burgio,
...
Kathryn McKeon,
James M. Byers,
Charlotte Burrin,
A. Enders,
L. Miosge,
Pablo F Cañete,
M. Jelušić,
V. Tasic,
A. Lungu,
S. Alexander,
A. Kitching,
D. Fulcher,
N. Shen,
T. Arsov,
P. Gatenby,
J. Babon,
Dominic Mallon,
C. de Lucas Collantes,
Eric A. Stone,
Philip Wu,
M. Field,
T. Andrews,
Eun Cho,
V. Pascual,
M. Cook,
C. Vinuesa
|
6 |
2019 |
6 🐜
|
🐜
|
Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis
17 auth.
F. Minoia,
F. Bovis,
S. Davì,
A. Horne,
M. Fischbach,
M. Frosch,
A. Huber,
M. Jelušić,
S. Sawhney,
D. McCurdy,
...
C. Silva,
D. Rigante,
E. Unsal,
N. Ruperto,
A. Martini,
R. Cron,
A. Ravelli
|
6 |
2019 |
6 🐜
|
🦁
|
Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used?
M. Jelušić,
M. Šestan,
R. Cimaz,
S. Ozen
|
5 |
2019 |
5 🦁
|
🐜
|
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseases
26 auth.
N. T. ter Haar,
Charlotte Eijkelboom,
L. Cantarini,
R. Papa,
P. Brogan,
I. Koné-Paut,
C. Modesto,
M. Hofer,
N. Iagăru,
Š. Fingerhutová,
A. Insalaco,
F. Licciardi,
Y. Uziel,
M. Jelušić,
I. Nikishina,
...
S. Nielsen,
E. Papadopoulou-Alataki,
A. Olivieri,
R. Cimaz,
G. Sušić,
V. Staņēviča,
M. V. van Gijn,
A. Vitale,
N. Ruperto,
J. Frenkel,
M. Gattorno
|
5 |
2019 |
5 🐜
|
🐢
|
The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus
D. Bobek,
D. Grčević,
N. Kovacic,
I. Lukić,
M. Jelušić
|
5 |
2014 |
5 🐢
|
🦁
|
Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis
7 auth.
M. Jelušić,
I. Lukić,
L. Tambić-Bukovac,
K. Dubravčić,
I. Malcic,
I. Rudan,
...
D. Batinić
|
5 |
2006 |
5 🦁
|
🐬
|
Depression, anxiety and pain in children with juvenile idiopathic arthritis (JIA)
B. Margetić,
B. Aukst-Margetić,
E. Bilic,
M. Jelušić,
L. Tambić Bukovac
|
5 |
2005 |
5 🐬
|
🐜
|
Elicitation of Expert Prior Opinion: Application to the MYPAN Trial in Childhood Polyarteritis Nodosa
22 auth.
Lisa V. Hampson,
J. Whitehead,
D. Eleftheriou,
C. Tudur-Smith,
Rachel A. Jones,
D. Jayne,
H. Hickey,
M. Beresford,
C. Bracaglia,
Afonso Caldas,
...
R. Cimaz,
J. Dehoorne,
P. Doležalová,
M. Friswell,
M. Jelušić,
S. Marks,
N. Martin,
A. McMahon,
J. Peitz,
A. van Royen-Kerkhof,
O. Soylemezoglu,
P. Brogan
|
5 |
2015 |
5 🐜
|